Skip to main content

Home/ Dogs-to-Stars Enterprises/ Group items tagged risk

Rss Feed Group items tagged

Scott Edelman

Infosecurity (USA) - ISACA launches risk management certification - 0 views

  • Security organization ISACA has launched a new risk management qualification for information security professionals. The Certified in Risk and Information Systems Control (CRISC) certification targets professionals in the IT area who use information security controls to manage risk in technology environments.
  • ISACA, which focuses on audit, risk, and governance disciplines, will administer the first CRISC examination next year
  • This is the fourth certification launched by ISACA. It also offers the Certified Information Systems Auditor (CISA), Certified Information Security Manager (CISM), and the Certified in the Governance of Enterprise IT (CGEIT), which is its most recent certification, launched in 2006.ISACA is also the publisher of the Risk IT standard for managing risk in IT, and the COBIT standard for IT governance.
dhtobey Tobey

Evidence-based medicine - Wikipedia, the free encyclopedia - 1 views

  • The systematic review of published research studies is a major method used for evaluating particular treatments. The Cochrane Collaboration is one of the best-known, respected examples of systematic reviews. Like other collections of systematic reviews, it requires authors to provide a detailed and repeatable plan of their literature search and evaluations of the evidence. Once all the best evidence is assessed, treatment is categoried as "likely to be beneficial", "likely to be harmful", or "evidence did not support either benefit or harm".
    • dhtobey Tobey
       
      We need to find access to the Cochrane Collaboration -- this is obviously a large, extant community socializing the vetting of clinical evidence.  We should find out more about their methodology and supporting technology, if any.
  • Evidence-based medicine categorizes different types of clinical evidence and ranks them according to the strength of their freedom from the various biases that beset medical research. For example, the strongest evidence for therapeutic interventions is provided by systematic review of randomized, double-blind, placebo-controlled trials involving a homogeneous patient population and medical condition. In contrast, patient testimonials, case reports, and even expert opinion have little value as proof because of the placebo effect, the biases inherent in observation and reporting of cases, difficulties in ascertaining who is an expert, and more.
    • dhtobey Tobey
       
      Is this ranking an emergent process supported by some type of knowledge exchange platform? What about consensus/dissensus analysis? Seems ripe for groupthink and manipulation or paradigm traps.
  • ...5 more annotations...
  • This process can be very human-centered, as in a journal club, or highly technical, using computer programs and information techniques such as data mining.
  • Level III: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.
    • dhtobey Tobey
       
      Need for LivingSurvey, LivingPapers, and LivingAnalysis.
  • Despite the differences between systems, the purposes are the same: to guide users of clinical research information about which studies are likely to be most valid. However, the individual studies still require careful critical appraisal.
    • dhtobey Tobey
       
      In other words, there are wide differences of opinion (dissensus) that must be managed and used to inform decision-making.
  • The U.S. Preventive Services Task Force uses:[9] Level A: Good scientific evidence suggests that the benefits of the clinical service substantially outweighs the potential risks. Clinicians should discuss the service with eligible patients. Level B: At least fair scientific evidence suggests that the benefits of the clinical service outweighs the potential risks. Clinicians should discuss the service with eligible patients. Level C: At least fair scientific evidence suggests that there are benefits provided by the clinical service, but the balance between benefits and risks are too close for making general recommendations. Clinicians need not offer it unless there are individual considerations. Level D: At least fair scientific evidence suggests that the risks of the clinical service outweighs potential benefits. Clinicians should not routinely offer the service to asymptomatic patients. Level I: Scientific evidence is lacking, of poor quality, or conflicting, such that the risk versus benefit balance cannot be assessed. Clinicians should help patients understand the uncertainty surrounding the clinical service.
    • dhtobey Tobey
       
      Relates well to Scott's idea of common problem being one of risk management.
  • AUC-ROC The area under the receiver operating characteristic curve (AUC-ROC) reflects the relationship between sensitivity and specificity for a given test. High-quality tests will have an AUC-ROC approaching 1, and high-quality publications about clinical tests will provide information about the AUC-ROC. Cutoff values for positive and negative tests can influence specificity and sensitivity, but they do not affect AUC-ROC.
    • dhtobey Tobey
       
      ROC curves are similar to PPT, though addressing a different and less impactful issue of system sensitivity and specificity, rather than reliability (consistency) as determined by PPT.
Steve King

Summary - 1 views

  • CHAPTER 4 FRAMEWORK FOR SCADA UTILITY SURVIVABILITY MODELING * 4.1 Risk Modeling * 4.2 Internet Survey * 4.3 Survivability * 4.4 Taxonomy for Assessing Computer Security * 4.5 Definitions and Terms for a Taxonomy * 4.6 Understanding the Taxonomy * 4.7 Hierarchical Holographic Modeling (HHM) * 4.8 Recent Uses of the HHM in Identifying Risks * 4.9 Risk Modeling Using HHM * 4.10 Goal Development and Indices of Performance * 4.11 Event Tree and Fault Tree Analysis * 4.12 Distributions from Event Tree Analysis * 4.13 Partitioned Multiobjective Risk Method * 4.14 Multiobjective Tradeoff Analysis * 4.15 Evaluation *
Steve King

UC Berkeley, Management of Technology (MOT) Program Course: Human and Organizational Fa... - 0 views

  • This course advances the concept that humans and their organizations are an integral part of the engineering paradigm and that it is up to engineering to learn how to better integrate considerations of people into engineering systems of all types. This course focuses this concept on the assessment and management of the risks associated with engineered systems during their life-cycle (concept development through decommissioning). Risks (likelihoods and consequences) are addressed in the contexts of the desired quality from an engineered system including serviceability (fitness for purpose), safety (freedom from undue exposure to harm), compatibility (on time, on budget, with happy customers including the environment), and durability (freedom from unexpected degradations in the other quality characteristics). Reliability is introduced to enable assessment of the wide variety of hazards, uncertainties, and variabilities that are present during the life-cycle of an engineered system. Proactive (get ahead of the challenges), Reactive (learn the lessons from successes and failures), and Interactive (realtime assessment and management of unknown knowables and unknown unknowables) strategies are advanced and illustrated to assist engineers in the assessment and management of risks.
Steve King

The Known, the Unknown, and the Unknowable in Financial Risk ... - 0 views

  •  
    I'm not sure I fully understand the KuU distinction.. but there seems to be thread of this stuff in high end risk theory.. leading back to this paper and beyond Gomory, R. (1995), "The Known, the Unknown and the Unknowable," Scientific American, June.
dhtobey Tobey

Startup Vertex Capital lends where banks won't - New Mexico Business Weekly: - 0 views

  • Luckily for Hydro Air, an alternative source of money – $500,000 worth – was available from an Albuquerque startup that will give businesses a line of credit based on their accounts receivables. Vertex Capital Group recently gave Hydro Air that line of credit and could help other small and large businesses get access to capital while the economy sits in a constricted lending environment, said Vertex CEO and Managing Partner Tim Vatuone.
  •  
    Could be another prospect for the Entrepreneurs Community Desktop to lower risk of their debt-financing initiatives.
Steve King

Technology Review: Technology's disasters share long trail of hubris - 0 views

  • Bea categorizes disasters into four groups. One such group is when an organization simply ignores warning signs through overconfidence and incompetence. He thinks the BP spill falls into that category. Bea pointed to congressional testimony that BP ignored problems with a dead battery, leaky cement job and loose hydraulic fittings.
Steve King

ProModel - Healthcare Solutions - 0 views

  • New Technology Evaluation and Implementation Hospitals and healthcare systems are under greater pressure than ever to improve patient care, increase staff satisfaction, control or reduce costs, and meet insurance and government regulations and live up to industry watchdog best practices. To help meet these demands, providers must continue to implement new technology as part of the solutions or risk obsolescence.
dhtobey Tobey

NDRI :: National Development and Research Institutes, Inc. - 0 views

  • Founded in 1967, NDRI is a non-profit research and educational organization dedicated to advancing scientific knowledge in the areas of drug and alcohol abuse, treatment and recovery; HIV, AIDS and HCV; therapeutic communities; youth at risk; and related areas of public health, mental health, criminal justice, urban problems, prevention and epidemiology.
  •  
    Potential partner or customer.
dhtobey Tobey

University Physicians Healthcare - UPH Executive Bios - 0 views

  • Lawrence Aldrich President and Chief Executive Officer (CEO) Larry Aldrich is an attorney with over 25 years of proven leadership abilities in diverse business positions. As President and CEO he is responsible for various corporate departments at UPH, including Legal/Risk, Information Systems, Electronic Medical Records, Marketing/Business Development/Contracts Administration and Facilities. Prior to joining UPH, Larry was the founding Chief Operating Officer at The Critical Path Institute (C-Path), a non-profit medical research organization focused on improving the safety and efficacy of the drug development process through the U.S. Food and Drug Administration. He also served as the president and CEO of Tucson Newspapers. Larry received his law degree from Tulane Law School and his civil engineering degree from Georgia Institute of Technology.
    • dhtobey Tobey
       
      Aldrich is the former head of Tucson Ventures. Scott is arranging presentation after our presentation development call with Jeanine.
dhtobey Tobey

Company plans to sell genetic testing kit at drugstores - 0 views

  • Beginning Friday
  • drugstores across the nation will be able to pick up something new: a test to scan their genes for a propensity for Alzheimer's disease, breast cancer, diabetes and other ailments.
  • The test also claims to offer a window into the chances of becoming obese, developing psoriasis and going blind. For those thinking of starting a family, it could alert them to their risk of having a baby with cystic fibrosis, Tay-Sachs and other genetic disorders. The test also promises users insights into how caffeine, cholesterol-lowering drugs and blood thinners might affect them.
  • ...3 more annotations...
  • the plan being announced Tuesday by Pathway Genomics of San Diego to sell its Insight test at about 6,000 of Walgreens' 7,500 stores represents the boldest move yet to bring the power of modern molecular medicine to the mass market.
  • The Food and Drug Administration questioned Monday whether the test will be sold legally because it does not have the agency's approval. Critics have said that results will be too vague to provide much useful guidance because so little is known about how to interpret genetic markers.
  • Others have said that the test is irresponsible and could give many buyers a dangerous false sense of security or, conversely, needlessly alarm them.
  •  
    Pioneer in genomics diagnostics may begin to pave the way for more sophisticated, FDA-approved products. Scott, How does this compare with products you have been looking at?
1 - 11 of 11
Showing 20 items per page